DAFTAR PUSTAKA
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for Sepsis and Organ Failure and Guidelines for The Use of Innovative Therapies in Sepsis. Critical Care Medicine, 1992. Vol 20 no 6.
Appelmelk Bj, Lynn WA.2000.The Cause of Sepsis: Bacterial Cell Component
That Trigger the Cytokine Cascade. In: Dhainaut JF, Thijs L, Park G, Editors, Septic Shock. London. WB Saunders Co. pg. 21-39.
Balci C, Sungurtekin H, Gurses E, et al.2003. Usefulness of Procalcitonin for Diagnosis of Sepsis in The Intensive Care Unit. Critical Care.pg.85-90.
Bloch KC. Infectious Diseases In : Mc Phee SJ, Ganong WF. Pathophysiology of Disease. Fifth Edition. New York.2000. P:83-84.
Buchori, Prihatini.2006. Diagnosis Sepsis menggunakan Procalcitonin.Indonesian Journal of Clinical Pathology and Medical Laboratory, Vol.12, No.3, Juli: pg.131-7.
Chen, K., and Pohan, H.T., 2009. Penatalaksanaan Syok Septik. In: Sudoyo, A.W., Setiyohadi, B., Alwi, I., Simadibrata, M., Setiati, S., ed. Buku Ajar Ilmu Penyakit Dalam. 5th ed. Jakarta: Interna Publishing, 252-256.
Cheng, Baoli, et al. 2007."Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China." Critical care medicine 35.11 : pg. 2538-2546.
Dasenbrook, E., and Merlo, C., 2008. Critical Care. In: Le, T., Hong, P.C., and
Baudendistel, T.E., ed. First Aid for The Internal Medicine Boards. 2nd ed. USA: Mc Graw Hill,pg. 157-159.
Delevaux I, Andre M, Colombier M, et al.2003. Can Procalcitonin Measurement Help in Differentiating Between Bacterial Infection and Other Kinds of
Dellinger, R. Phillip, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan E. Sevransky et al. 2012. Surviving Sepsis Campaign: International Guidelines for Management of Severe
Sepsis and Septic Shock.Intensive care medicine 39, no. 2 (2013): 165-228.
Gaba, C., and I. Kushner.2000. Acute-phase proteins and other systemic response to inflammation.NEJM.340.6: pg.448-454.
Gossman, W.G., and Plantz, S.H., 2008. Pearls of Wisdom Emergency Medicine Oral Board Review. 5th ed. USA: Mc Graw Hill.
Guntur A H.2007. Sepsis. Dalam : Buku Ajar Ilmu Penyakit Dalam. Sudoyo AW, Setiyohadi B, Alwi I, dkk (Editor). Jakarta. Pusat Penerbitan Ilmu
Penyakit Dalam FK UI; 2007:1862-5
Guyton, AC. Hall JE. 2007. Buku Ajar Fisiologi Kedokteran.Edisi 11.Jakarta. EGC.
Hack CE, Thijs L.2000. Role of Inflammatory Mediators in Sepsis. In: Dhainaut JF Thijs L, Park G, eds. Septic Shock. London.WB Saunders Co. 2000. Page. 41-127.
Hammer C, Hobel G, Hamme S, et al.2002. Diagnosis and Monitoring of
Inflammatory Events in Transplant Patients.In:Trull Ak, Demers LM, Holt DW, et al. Biomarkers of Disease An Evidence-Based Approach
Cambridge University Press, Cambridge United Kingdom. pg.474-48.
Henry JB. 2003.High White Blood Cell Counts, In : Clinical Diagnosis And Management. 19th ed. WB. Saunders. pg. 81
Hinds, Moss, P.J., Langmead, L., Preston, S.L., C.J., Watson, D., Pearse, R.M., 2012. Kumar and Clark’s Clinical Medicine. 8th ed. Spanyol: Saunders
Elsevier.
Kasper, Braunwald, Fauci, Hauser, Longo, Jameson(Editors). 2005.Sepsis and Septic Shock. Harrison’s Manual Of Medicine.16 th Edition, Mc Graw Hill. pg.49-53.
Kosanke R, Beier W, Lipecky R, Meisner M. 2008. Clinical Benefits of Procalcitonin. Tannafos. 7:pg.14 – 18.
LaRosa, S.P., 2010. Sepsis. Dalam: Gordon, S., ed. Current Clinical Medicine.
2nd ed. Philadelphia: Saunders Elsevier, pg.720-725.
M. Sopiyudin Dahlan.2015. Statistik untuk kedokteran dan kesehatan. 6th ed. Jakarta: Salemba Medika.pg. 224
Meisner M, Brunkhorst FM, Reith H, Schmidt J, et al. 2000.Clinical Experiences with a New Semi-Quantitative Solid Phase Immunoassay for Rapid
Measurement of Procalcitonin. Clin Chem Lab Med. 38(10): pg. 989-95.
Meisner M, Tschaikowsky K, Schabel S, et al. 1997.PCT - Influence of Temperature, Storage, Anticoagulation and Arterial or Venous
Asservation Of Blood Samples on Procalcitonin Concentrations. Eur J. Clin Chem. Clin Biochem,35 (8): pg.597-60.
Meisner M. 2002. Pathobiochemistry and Clinical Use of Procalcitonin. Clinica Chimica Acta. 323.pg. 17-29.
Meisner M.2005. Biomarkers of Sepsis : Clinically Useful ?. Current Opinion in Critical Care,11.pg. 473 – 480.
Munford, R.S., 2008. Severe Sepsis and Septic Shock. Dalam: Fauci et al., ed.
Harrison,s Principles of Internal Medicine. 17th ed. USA: Mc Graw Hill,
1695-1702.
Murzalina, Cut.2008. Procalcitonin pada pasien sepsis yang telah mendapat
Nasronudin,2007. Perubahan Mediator selama Perjalanan Sepsis. Dalam : SEPSIS. Penyakit Infeksi di Indonesia. Nasronudin, Hadi Usman, Vitanata, dkk (Editor). Surabaya.Airlangga University Press;hal. 257-262.
O'Connor E, Venkatesh B, lipman J, et al.2001. Procalcitonin in Critical Illness. Critical Care and Resuscitation.3.pg. 236-243.
Pohan HT. 2005.Pemeriksaan Procalcitonin untuk Diagnosis Infeksi Berat.
dalam: Pohan HT, Widodo D (editor), Penyakit Infeksi. Jakarta: FKUI; 2004. hal: 32-9.
Purba, Donald Boy P. 2011. Procalcitonin Sebagai Marker dan Hubungannya dengan Derajat Keparahan Sepsis. Karya Tulis Ilmiah. Sumatera Utara: Fakultas Kedokteran, Universitas Sumatera Utara.
Raghavan M, Marik PE. 2006.Management of Sepsis During the Early “Golden Hours”. The Journal of Emergency Medicine, Vol 31, No.2. pp.185-99.
Rau B, Kruger CM, Schilling M K. 2004. Procalcitonin : Improved Biochemical Severity Stratification and Post Operative Monitoring in Severe
Abdominal Inflammation and Sepsis. Langenbecks Arch Surg;pg. 389: 134-144.
Robert S. Munford, 2008. Harrison’s Internal Medicine, 17th Edition, USA, McGraw – Hill, page 1695-1699.
Russell, J.A., 2012. Shock Syndromes Related to Sepsis. In: Goldman, L., and Schaffer, A.I., ed. Goldman’s Cecil Medicine. 24th ed. Philadelphia: Elsevier Saunders, pg.658-665.
Saadat, S., 2008. Deja Review Internal Medicine. USA: Mc Graw Hill.
Shapiro, N.I., Zimmer, G.D., and Barkin, A.Z., 2010. Sepsis Syndromes. In: Marx
Sherwood, Lauralee. 2012. Fisiologi Manusia dari Sel ke Sistem.Edisi 6. Jakarta. EGC
Simon L, Gauvin F, Amre DK, et al. 2004.Serum Procalcitonin and C-Reaktive Protein Levels as Marker of Bacterial Infection : A Systematic Review and
Meta-analysis. Clinical Infectious Diseases;39th: pg. 206 – 17.
Sudigdo S, Sofyan I. 2014.Dasar-dasar metodologi penelitian klinis:5th ed.
Jakarta: Sagung Seto.pg. 345.
Suharto, Nasronudin, Kuntaman, 2007. Penyakit Infeksi di Indonesia Solusi Kini dan Mendatang. Artikel. Surabaya: Airlangga University Press.
Vienna. 2000.Procalcitonin- a New Marker of The Systemic Inflammatory
Response to Infections. Klinik Fur Anasthesiaologie und Intensiv Therapie J ena, Germany.
Weber, R., and Fontana, A., 2007. Fever. In: Siegenthaler, W., ed. Differential Diagnosis in Internal Medicine from Symptom to Diagnosis. Stuttgart: Thieme, pg. 106-203.
